Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...
Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the developm...
EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gu...
The €190 million acquisition of VISUfarma marks a pivotal moment in Lupin’s transformation into a global specialty-led biopharma. With VISUfarma...
Industry report measures progress in six main areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, government polic...
NurExone Biologic Inc. , a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the United S...
World’s #1 Selling Contact Lens Brand ACUVUE® brings pioneering innovation for astigmatic patients, providing visual clarity and comfort Johns...
SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to...
-PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announ...
The strategic partnership between AstraZeneca and Revna Biosciences is rapidly transforming the landscape of lung cancer care in Ghana. Since the initial...
© 2025 Biopharma Boardroom. All Rights Reserved.
